CAS 2245255-66-5

(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt

CAS: 2245255-66-5

Formula: C₂₁H₃₃F₃N₈O₇

Purity: 98%

Color and Shape: Solid

Molecular weight: 566.5313

Ref: IN-DA01FHIK

GSK2807 Trifluoroacetate

CAS: 2245255-66-5

GSK2807 Trifluoroacetate

Purity: ≥98%

Molecular weight: 566.53g/mol

Ref: 54-BUP01718

GSK2807 Trifluoroacetate

CAS: 2245255-66-5

GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).

Formula: C₂₁H₃₃F₃N₈O₇

Purity: 99.95%

Color and Shape: Solid

Molecular weight: 566.53

Ref: TM-T11486

(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt

CAS: 2245255-66-5

Purity: 98%

Molecular weight: 566.5390015

Ref: 10-F867074

GSK2807 Trifluoroacetate

CAS: 2245255-66-5

GSK2807 Trifluoroacetate is a selective inhibitor, specifically targeting the lysine acetyltransferase MYST3 (MOZ), which is derived synthetically through medicinal chemistry. This compound functions by competitively inhibiting the acetylation of histone lysine residues, crucial components in the regulation of gene expression through chromatin modification. The inhibition of MYST3 disrupts its role in facilitating transcriptional activation by modulating chromatin structure, thereby impairing the recruitment of transcription factors and other co-regulatory proteins essential for gene expression.

Formula: C₂₁H₃₃F₃N₈O₇

Purity: Min. 95%

Molecular weight: 566.53 g/mol

Ref: 3D-VPD25566